Nordimet 7.5 mg

NORDIMET 7.5 MG is a subcutaneous solution containing Methotrexate Sodium, used for various medical conditions. This medication is manufactured by Nordic Group B.V. in the Netherlands.

NORDIMET 7.5 MG is primarily used for the treatment of certain types of cancer, rheumatoid arthritis, and psoriasis. Methotrexate Sodium, the active ingredient, works by interfering with the growth of certain cells in the body. It is often prescribed for conditions where cell growth needs to be controlled or reduced.

Common effects of NORDIMET 7.5 MG may include nausea, fatigue, and mild skin irritation at the injection site. Some users might experience temporary hair loss or mouth sores. These effects vary among individuals and are not experienced by everyone.

NORDIMET 7.5 MG should be handled with care and stored as directed. It is important to follow the healthcare provider's instructions for administration. Pregnant women or those planning to become pregnant should discuss the use of this medication with their healthcare provider.

NORDIMET 7.5 MG may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, and other drugs that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.